R. Taberner

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

Satveer K. Mahil, Nick Dand, K.J. Mason et al. · Journal of Allergy and Clinical Immunology · 2020 · 158 citations · Full text

Adverse Covid-19 Outcomes, Global Health, Covid-19 Pandemic +9

Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting

R. Navarro Suay, Eva Vilarrasa, Pedro Herranz et al. · British Journal of Dermatology · 2012 · 99 citations

Spanish Evidence-Based Guidelines on the Treatment of Psoriasis With Biologic Agents, 2013. Part 1: On Efficacy and Choice of Treatment

L. Puig, J.M. Carrascosa, G. Carretero et al. · Actas Dermo-Sifiliográficas · 2013 · 62 citations · Full text

Guidelines on the Use of Methotrexate in Psoriasis

G. Carretero, L. Puig, Luis Dehesa et al. · Actas Dermo-Sifiliográficas · 2010 · 46 citations · Full text

Spanish Population, Psoriasis Group, Pharmacology +11

Effects of COVID-19 Lockdown on Tumour Burden of Melanoma and Cutaneous Squamous Cell Carcinoma

A. Tejera‐Vaquerizo, Sabela Paradela, Agustí Toll et al. · Acta Dermato Venereologica · 2021 · 38 citations · Full text

Surgical Oncology, Epidemiology Of Cancer, Median Tumour Burden +21